Selim Merdan

3PUBLICATIONS
7CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Sep 15, 2026
VISTA as a myeloid-centered checkpoint axis in cancer: biology, tumor microenvironment, and therapeutic implications.

|Aug 21, 2026
Overcoming resistance to immune checkpoint inhibitors in cancer: translational mechanisms, dynamic biomarkers, clinically actionable combination strategies, and comparative checkpoint biology.

|Oct 08, 2024
Evaluation of CD56 and CD117 Double-Positivity as a Predictor of Poor Prognosis in Multiple Myeloma Patients: A Retrospective Analysis

Hakan Keski, Selim Merdan, Itır Ebru Zemheri

Pageof 1

Frequent Collaborators

2 joint publications

Rumeysa Berra Karataş

2 joint publications

Yaren Alras

2 joint publications

Sarenur Teki̇ner

2 joint publications

Kaan Zıkşahna

2 joint publications

Murat Ihlamur

1 joint publications

Hakan Keski

1 joint publications

Itır Ebru Zemheri

Frequent Collaborators

2 joint publications

Rumeysa Berra Karataş

2 joint publications

Yaren Alras

2 joint publications

Sarenur Teki̇ner

2 joint publications

Kaan Zıkşahna

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us